Supported by four dedicated research coordinators, our clinical research program's past and current research areas have included genetics of abdominal aortic aneurysm and peripheral artery disease; novel stents for treatment of thoracic and abdominal aortic aneurysms; evaluation of new catheter based strategies, drugs, and gene therapy for treatment of peripheral arterial disease; artificial blood vessels; new devices for prevention of stroke and treatment of carotid disease; and artificial venous valves. Patients have the opportunity to benefit from cutting-edge technology through the more than 24 FDA approved clinical trials conducted by program investigators.

The basic science research program has received over $16.7 million of funding from the NIH, NSF, and JDRF over the past 11 years. Projects are ongoing in the areas of reparative medicine, organ fabrication, and the design of engineered living systems. The program is integrated with The Wallace Coulter Department of Biomedical Engineering at Georgia Tech and Emory and the Department of Chemistry at Emory. Projects are ongoing in the areas of reparative medicine, organ fabrication, and the design of engineered living systems. For detailed information about the program, visit the lab's official website.